Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

Por Marta Gascón, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, Alfonso Yubero, Julián Pardo, Luis Martínez-Lostao
Publicado em 2020-06-01

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

Por Maitane Ocáriz-Díez, Maitane Ocáriz-Díez, Mara Cruellas, Mara Cruellas, Marta Gascón, Marta Gascón, Rodrigo Lastra, Rodrigo Lastra, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Ariel Ramírez-Labrada, José Ramón Paño, José Ramón Paño, Andrea Sesma, Andrea Sesma, Irene Torres, Irene Torres, Alfonso Yubero, Alfonso Yubero, Julián Pardo, Julián Pardo, Julián Pardo, Julián Pardo, Dolores Isla, Dolores Isla, Eva M. Gálvez
Publicado em 2020-09-01